Microsoft Continues Partnership With Nokia and 3 Dow Movers to Follow
JPMorgan Chase & Co. (NYSE:JPM): Current price $46.43
The firm’s Co-Chief Control Officer Cindy Armine will replace Martha Gallo as the new global head of compliance, according to The Financial Times. Gallo has served as the bank’s compliance chief for more than two years, and will remain with the company.
3M Company (NYSE:MMM): Current price $99.65
The company expects foreign currency translation to be neutral for 2013. Also, its earnings guidance includes a 10-cent tailwind from lower pension/OPEB expense. These observations were taken from slides that will be presented on the fourth quarter earnings conference call.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Microsoft Corporation (NASDAQ:MSFT): Current price $28.00
Nokia Corporation (NYSE:NOK) said again that it is collaborating with Microsoft so as to take Windows Phone to devices with “lower and lower price points,” and denied rumors to the effect that it is thinking about using Google’s (NASDAQ:GOOG) Android OS, said TechCrunch, citing comments made by the Nokia Chief Executive Stephen Elop on the company’s fourth quarter earnings conference call.
Pfizer (NYSE:PFE): Current price $27.10
Pfizer said that a Phase 4 study evaluating the efficacy and safety of Toviaz (fesoterodine fumarate) 8 mg once daily in patients with overactive bladder compared to Toviaz 4 mg once daily or placebo met its primary endpoint, being change in mean number of urge urinary incontinence episodes per 24 hours from baseline to week 12. Toviaz 8 mg decreased urge urinary incontinence in patients suffering with OAB statistically significantly more than Toviaz 4 mg, and the efficacy of both doses was statistically significant versus placebo. The most common treatment-emergent side effects were dry mouth, constipation and urinary tract infection.